Advertisement

2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary

A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Published:September 23, 2015DOI:https://doi.org/10.1016/j.hrthm.2015.09.018
      Jonathan L. Halperin, MD, FACC, FAHA, Chair

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (U.S.)
        Clinical Practice Guidelines We Can Trust.
        National Academies Press, Washington, DC2011
        • Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (U.S.)
        Finding What Works in Health Care: Standards for Systematic Reviews.
        National Academies Press, Washington, DC2011
      1. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Available at: http://assets.cardiosource.com/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdf and http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/documents/downloadable/ucm_319826.pdf. Accessed January 23, 2015.

        • Jacobs A.K.
        • Kushner F.G.
        • Ettinger S.M.
        • et al.
        ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 61: 213-265
        • Jacobs A.K.
        • Anderson J.L.
        • Halperin J.L.
        The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 64: 1373-1384
        • Anderson J.L.
        • Heidenreich P.A.
        • Barnett P.G.
        • et al.
        ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 63: 2304-2322
        • Halperin J.L.
        • Levine G.N.
        • Al-Khatib S.M.
        Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines.
        J Am Coll Cardiol. 2015; (In press. http://dx.doi.org/10.1016/j.jacc.2015.09.001)
        • Arnett D.K.
        • Goodman R.A.
        • Halperin J.L.
        • et al.
        AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services.
        J Am Coll Cardiol. 2014; 64: 1851-1856
        • Page R.L.
        • Joglar J.A.
        • Al-Khatib S.M.
        • et al.
        2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2015; (In press. http://dx.doi.org/10.1016/j.jacc.2015.09.019)
        • Al-Khatib S.M.
        • Arshad A.
        • Balk E.M.
        • et al.
        Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2015; (In press. http://dx.doi.org/10.1016/j.jacc.2015.09.018)
        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • et al.
        2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2014; 64: 2246-2280
        • Blomström-Lundqvist C.
        • Scheinman M.M.
        • Aliot E.M.
        • et al.
        ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Developed in collaboration with NASPE-Heart Rhythm Society.
        J Am Coll Cardiol. 2003; 42: 1493-1531
        • Orejarena L.A.
        • Vidaillet H.
        • DeStefano F.
        • et al.
        Paroxysmal supraventricular tachycardia in the general population.
        J Am Coll Cardiol. 1998; 31: 150-157
        • Lu C.-W.
        • Wu M.-H.
        • Chen H.-C.
        • et al.
        Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation.
        Int J Cardiol. 2014; 174: 530-534
        • Whinnett Z.I.
        • Sohaib S.M.A.
        • Davies D.W.
        Diagnosis and management of supraventricular tachycardia.
        BMJ. 2012; 345: e7769
        • Porter M.J.
        • Morton J.B.
        • Denman R.
        • et al.
        Influence of age and gender on the mechanism of supraventricular tachycardia.
        Heart Rhythm. 2004; 1: 393-396
        • Goyal R.
        • Zivin A.
        • Souza J.
        • et al.
        Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia.
        Am Heart J. 1996; 132: 765-767
        • Maryniak A.
        • Bielawska A.
        • Bieganowska K.
        • et al.
        Does atrioventricular reentry tachycardia (AVRT) or atrioventricular nodal reentry tachycardia (AVNRT) in children affect their cognitive and emotional development?.
        Pediatr Cardiol. 2013; 34: 893-897
        • González-Torrecilla E.
        • Almendral J.
        • Arenal A.
        • et al.
        Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation.
        J Am Coll Cardiol. 2009; 53: 2353-2358
        • Liu S.
        • Yuan S.
        • Hertervig E.
        • et al.
        Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.
        J Electrocardiol. 2001; 34: 295-301
        • Anand R.G.
        • Rosenthal G.L.
        • Van Hare G.F.
        • et al.
        Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity?.
        Congenit Heart Dis. 2009; 4: 464-468
        • Walfridsson U.
        • Strömberg A.
        • Janzon M.
        • et al.
        Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life.
        Pacing Clin Electrophysiol. 2009; 32: 1299-1306
        • Cain N.
        • Irving C.
        • Webber S.
        • et al.
        Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood.
        Am J Cardiol. 2013; 112: 961-965
        • Laurent G.
        • Leong-Poi H.
        • Mangat I.
        • et al.
        Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardia.
        J Cardiovasc Electrophysiol. 2009; 20: 176-181
        • Auricchio A.
        • Klein H.
        • Trappe H.J.
        • et al.
        Lack of prognostic value of syncope in patients with Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1991; 17: 152-158
        • Drago F.
        • Turchetta A.
        • Calzolari A.
        • et al.
        Reciprocating supraventricular tachycardia in children: low rate at rest as a major factor related to propensity to syncope during exercise.
        Am Heart J. 1996; 132: 280-285
        • Kalusche D.
        • Ott P.
        • Arentz T.
        • et al.
        AV nodal re-entry tachycardia in elderly patients: clinical presentation and results of radiofrequency catheter ablation therapy.
        Coron Artery Dis. 1998; 9: 359-363
        • Haghjoo M.
        • Arya A.
        • Heidari A.
        • et al.
        Electrophysiologic characteristics and results of radiofrequency catheter ablation in elderly patients with atrioventricular nodal reentrant tachycardia.
        J Electrocardiol. 2007; 40: 208-213
        • Walfridsson U.
        • Walfridsson H.
        The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation.
        Pacing Clin Electrophysiol. 2005; 28: 191-195
        • Letsas K.P.
        • Weber R.
        • Siklody C.H.
        • et al.
        Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway.
        Acta Cardiol. 2010; 65: 171-176
        • Knight B.P.
        • Ebinger M.
        • Oral H.
        • et al.
        Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia.
        J Am Coll Cardiol. 2000; 36: 574-582
        • Murman D.H.
        • McDonald A.J.
        • Pelletier A.J.
        • et al.
        U.S. emergency department visits for supraventricular tachycardia, 1993-2003.
        Acad Emerg Med. 2007; 14: 578-581
        • Lim S.H.
        • Anantharaman V.
        • Teo W.S.
        • et al.
        Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage.
        Ann Emerg Med. 1998; 31: 30-35
        • Luber S.
        • Brady W.J.
        • Joyce T.
        • et al.
        Paroxysmal supraventricular tachycardia: outcome after ED care.
        Am J Emerg Med. 2001; 19: 40-42
        • Waxman M.B.
        • Wald R.W.
        • Sharma A.D.
        • et al.
        Vagal techniques for termination of paroxysmal supraventricular tachycardia.
        Am J Cardiol. 1980; 46: 655-664
        • Brady W.J.
        • DeBehnke D.J.
        • Wickman L.L.
        • et al.
        Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil.
        Acad Emerg Med. 1996; 3: 574-585
        • Cairns C.B.
        • Niemann J.T.
        Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia.
        Ann Emerg Med. 1991; 20: 717-721
        • Gausche M.
        • Persse D.E.
        • Sugarman T.
        • et al.
        Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.
        Ann Emerg Med. 1994; 24: 183-189
        • Madsen C.D.
        • Pointer J.E.
        • Lynch T.G.
        A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting.
        Ann Emerg Med. 1995; 25: 649-655
        • McCabe J.L.
        • Adhar G.C.
        • Menegazzi J.J.
        • et al.
        Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia.
        Ann Emerg Med. 1992; 21: 358-361
        • Rankin A.C.
        • Oldroyd K.G.
        • Chong E.
        • et al.
        Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.
        Br Heart J. 1989; 62: 195-203
        • Lim S.H.
        • Anantharaman V.
        • Teo W.S.
        • et al.
        Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
        Resuscitation. 2009; 80: 523-528
        • DiMarco J.P.
        • Miles W.
        • Akhtar M.
        • et al.
        Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
        Ann Intern Med. 1990; 113: 104-110
        • Roth A.
        • Elkayam I.
        • Shapira I.
        • et al.
        Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states.
        Am J Cardiol. 2003; 91: 489-491
        • Stec S.
        • Kryñ̆ski T.
        • Kułakowski P.
        Efficacy of low energy rectilinear biphasic cardioversion for regular atrial tachyarrhythmias.
        Cardiol J. 2011; 18: 33-38
        • Lim S.H.
        • Anantharaman V.
        • Teo W.S.
        Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia.
        Resuscitation. 2002; 52: 167-174
        • Gupta A.
        • Naik A.
        • Vora A.
        • et al.
        Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
        J Assoc Physicians India. 1999; 47: 969-972
        • Dorian P.
        • Naccarelli G.V.
        • Coumel P.
        • et al.
        A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
        Am J Cardiol. 1996; 77: 89A-95A
        • Mauritson D.R.
        • Winniford M.D.
        • Walker W.S.
        • et al.
        Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial.
        Ann Intern Med. 1982; 96: 409-412
        • Winniford M.D.
        • Fulton K.L.
        • Hillis L.D.
        Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil.
        Am J Cardiol. 1984; 54: 1138-1139
        • Jackman W.M.
        • Beckman K.J.
        • McClelland J.H.
        • et al.
        Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction.
        N Engl J Med. 1992; 327: 313-318
        • Hindricks G.
        The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology.
        Eur Heart J. 1993; 14: 1644-1653
        • Hindricks G.
        Incidence of complete atrioventricular block following attempted radiofrequency catheter modification of the atrioventricular node in 880 patients. Results of the Multicenter European Radiofrequency Survey (MERFS) The Working Group on Arrhythmias of the European Society of Cardiology.
        Eur Heart J. 1996; 17: 82-88
        • Spector P.
        • Reynolds M.R.
        • Calkins H.
        • et al.
        Meta-analysis of ablation of atrial flutter and supraventricular tachycardia.
        Am J Cardiol. 2009; 104: 671-677
        • Calkins H.
        • Yong P.
        • Miller J.M.
        • et al.
        Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group.
        Circulation. 1999; 99: 262-270
        • Scheinman M.M.
        • Huang S.
        The 1998 NASPE prospective catheter ablation registry.
        Pacing Clin Electrophysiol. 2000; 23: 1020-1028
        • Cheng C.H.
        • Sanders G.D.
        • Hlatky M.A.
        • et al.
        Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia.
        Ann Intern Med. 2000; 133: 864-876
        • Bohnen M.
        • Stevenson W.G.
        • Tedrow U.B.
        • et al.
        Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias.
        Heart Rhythm. 2011; 8: 1661-1666
        • Tendera M.
        • Wnuk-Wojnar A.M.
        • Kulakowski P.
        • et al.
        Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
        Am Heart J. 2001; 142: 93-98
      2. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
        Circulation. 1995; 92: 2550-2557
        • Chimienti M.
        • Cullen M.T.
        • Casadei G.
        Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
        Eur Heart J. 1995; 16: 1943-1951
        • Anderson J.L.
        • Platt M.L.
        • Guarnieri T.
        • et al.
        Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
        Am J Cardiol. 1994; 74: 578-584
        • Pritchett E.L.
        • DaTorre S.D.
        • Platt M.L.
        • et al.
        Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
        J Am Coll Cardiol. 1991; 17: 297-303
        • Pritchett E.L.
        • McCarthy E.A.
        • Wilkinson W.E.
        Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
        Ann Intern Med. 1991; 114: 539-544
        • Henthorn R.W.
        • Waldo A.L.
        • Anderson J.L.
        • et al.
        Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
        Circulation. 1991; 83: 119-125
        • Wanless R.S.
        • Anderson K.
        • Joy M.
        • et al.
        Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias.
        Am Heart J. 1997; 133: 441-446
        • Gambhir D.S.
        • Bhargava M.
        • Nair M.
        • et al.
        Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
        Indian Heart J. 1996; 48: 133-137
        • Haines D.E.
        • Beheiry S.
        • Akar J.G.
        • et al.
        Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety.
        Heart Rhythm. 2014; 11: e9-e51
        • Knight B.P.
        • Zivin A.
        • Souza J.
        • et al.
        A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory.
        J Am Coll Cardiol. 1999; 33: 775-781
        • Horowitz L.N.
        • Kay H.R.
        • Kutalek S.P.
        • et al.
        Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients.
        J Am Coll Cardiol. 1987; 9: 1261-1268
        • Asirvatham S.
        • Narayan O.
        Advanced catheter mapping and navigation system.
        in: Huang S.W. Wood M. Catheter Ablation of Cardiac Arrhythmias. Saunders/Elsevier, Philadelphia, PA2006: 135-161
        • Sporton S.C.
        • Earley M.J.
        • Nathan A.W.
        • et al.
        Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study.
        J Cardiovasc Electrophysiol. 2004; 15: 310-315
        • Alvarez M.
        • Tercedor L.
        • Almansa I.
        • et al.
        Safety and feasibility of catheter ablation for atrioventricular nodal re-entrant tachycardia without fluoroscopic guidance.
        Heart Rhythm. 2009; 6: 1714-1720
        • Casella M.
        • Pelargonio G.
        • Dello R.A.
        • et al.
        “Near-zero” fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX mapping system: personal experience and review of the literature.
        J Interv Card Electrophysiol. 2011; 31: 109-118
        • Razminia M.
        • Manankil M.F.
        • Eryazici P.L.S.
        • et al.
        Nonfluoroscopic catheter ablation of cardiac arrhythmias in adults: feasibility, safety, and efficacy.
        J Cardiovasc Electrophysiol. 2012; 23: 1078-1086
        • Earley M.J.
        • Showkathali R.
        • Alzetani M.
        • et al.
        Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial.
        Eur Heart J. 2006; 27: 1223-1229
        • Hindricks G.
        • Willems S.
        • Kautzner J.
        • et al.
        Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study.
        J Cardiovasc Electrophysiol. 2009; 20: 734-740
        • Xu D.
        • Yang B.
        • Shan Q.
        • et al.
        Initial clinical experience of remote magnetic navigation system for catheter mapping and ablation of supraventricular tachycardias.
        J Interv Card Electrophysiol. 2009; 25: 171-174
        • Sommer P.
        • Wojdyla-Hordynska A.
        • Rolf S.
        • et al.
        Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system.
        Europace. 2013; 15: 578-581
        • Cummings J.E.
        • Pacifico A.
        • Drago J.L.
        • et al.
        Alternative energy sources for the ablation of arrhythmias.
        Pacing Clin Electrophysiol. 2005; 28: 434-443
        • Olshansky B.
        • Sullivan R.M.
        Inappropriate sinus tachycardia.
        J Am Coll Cardiol. 2013; 61: 793-801
        • Marcus B.
        • Gillette P.C.
        • Garson A.
        Intrinsic heart rate in children and young adults: an index of sinus node function isolated from autonomic control.
        Am Heart J. 1990; 119: 911-916
        • Jose A.D.
        • Collison D.
        The normal range and determinants of the intrinsic heart rate in man.
        Cardiovasc Res. 1970; 4: 160-167
        • Alboni P.
        • Malcarne C.
        • Pedroni P.
        • et al.
        Electrophysiology of normal sinus node with and without autonomic blockade.
        Circulation. 1982; 65: 1236-1242
        • Cappato R.
        • Castelvecchio S.
        • Ricci C.
        • et al.
        Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
        J Am Coll Cardiol. 2012; 60: 1323-1329
        • Benezet-Mazuecos J.
        • Rubio J.M.
        • Farré J.
        • et al.
        Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients.
        Pacing Clin Electrophysiol. 2013; 36: 830-836
        • Ptaszynski P.
        • Kaczmarek K.
        • Ruta J.
        • et al.
        Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
        Europace. 2013; 15: 116-121
        • Ptaszynski P.
        • Kaczmarek K.
        • Ruta J.
        • et al.
        Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway.
        Pacing Clin Electrophysiol. 2013; 36: 42-49
        • Ptaszynski P.
        • Kaczmarek K.
        • Ruta J.
        • et al.
        Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
        J Cardiovasc Pharmacol Ther. 2013; 18: 338-344
        • Calò L.
        • Rebecchi M.
        • Sette A.
        • et al.
        Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia.
        Heart Rhythm. 2010; 7: 1318-1323
        • Kaplinsky E.
        • Comes F.P.
        • Urondo L.S.V.
        • et al.
        Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.
        Cardiol J. 2010; 17: 166-171
        • Rakovec P.
        Treatment of inappropriate sinus tachycardia with ivabradine.
        Wien Klin Wochenschr. 2009; 121: 715-718
        • Zellerhoff S.
        • Hinterseer M.
        • Felix Krull B.
        • et al.
        Ivabradine in patients with inappropriate sinus tachycardia.
        Naunyn Schmiedebergs Arch Pharmacol. 2010; 382: 483-486
        • Man K.C.
        • Knight B.
        • Tse H.F.
        • et al.
        Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping.
        J Am Coll Cardiol. 2000; 35: 451-457
        • Lin D.
        • Garcia F.
        • Jacobson J.
        • et al.
        Use of noncontact mapping and saline-cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia.
        Pacing Clin Electrophysiol. 2007; 30: 236-242
        • Lee R.J.
        • Kalman J.M.
        • Fitzpatrick A.P.
        • et al.
        Radiofrequency catheter modification of the sinus node for “inappropriate” sinus tachycardia.
        Circulation. 1995; 92: 2919-2928
        • Marrouche N.F.
        • Beheiry S.
        • Tomassoni G.
        • et al.
        Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome.
        J Am Coll Cardiol. 2002; 39: 1046-1054
        • Callans D.J.
        • Ren J.F.
        • Schwartzman D.
        • et al.
        Narrowing of the superior vena cava-right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: analysis with intracardiac echocardiography.
        J Am Coll Cardiol. 1999; 33: 1667-1670
        • Frankel D.S.
        • Lin D.
        • Anastasio N.
        • et al.
        Frequent additional tachyarrhythmias in patients with inappropriate sinus tachycardia undergoing sinus node modification: an important cause of symptom recurrence.
        J Cardiovasc Electrophysiol. 2012; 23: 835-839
        • Takemoto M.
        • Mukai Y.
        • Inoue S.
        • et al.
        Usefulness of non-contact mapping for radiofrequency catheter ablation of inappropriate sinus tachycardia: new procedural strategy and long-term clinical outcome.
        Intern Med. 2012; 51: 357-362
        • Klein I.
        • Ojamaa K.
        Thyroid hormone and the cardiovascular system.
        N Engl J Med. 2001; 344: 501-509
        • Steinbeck G.
        • Hoffmann E.
        ‘True’ atrial tachycardia.
        Eur Heart J. 1998; 19: E48-E49
        • Wren C.
        Incessant tachycardias.
        Eur Heart J. 1998; 19: E54-E59
        • Medi C.
        • Kalman J.M.
        • Haqqani H.
        • et al.
        Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation.
        J Am Coll Cardiol. 2009; 53: 1791-1797
        • Tang C.W.
        • Scheinman M.M.
        • Van Hare G.F.
        • et al.
        Use of P wave configuration during atrial tachycardia to predict site of origin.
        J Am Coll Cardiol. 1995; 26: 1315-1324
        • Kistler P.M.
        • Roberts-Thomson K.C.
        • Haqqani H.M.
        • et al.
        P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin.
        J Am Coll Cardiol. 2006; 48: 1010-1017
        • Chen S.A.
        • Chiang C.E.
        • Yang C.J.
        • et al.
        Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation.
        Circulation. 1994; 90: 1262-1278
        • Kalman J.M.
        • Olgin J.E.
        • Karch M.R.
        • et al.
        “Cristal tachycardias”: origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography.
        J Am Coll Cardiol. 1998; 31: 451-459
        • Morton J.B.
        • Sanders P.
        • Das A.
        • et al.
        Focal atrial tachycardia arising from the tricuspid annulus: electrophysiologic and electrocardiographic characteristics.
        J Cardiovasc Electrophysiol. 2001; 12: 653-659
        • Kistler P.M.
        • Sanders P.
        • Fynn S.P.
        • et al.
        Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation.
        Circulation. 2003; 108: 1968-1975
        • Kistler P.M.
        • Sanders P.
        • Hussin A.
        • et al.
        Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization.
        J Am Coll Cardiol. 2003; 41: 2212-2219
        • Gonzalez M.D.
        • Contreras L.J.
        • Jongbloed M.R.M.
        • et al.
        Left atrial tachycardia originating from the mitral annulus-aorta junction.
        Circulation. 2004; 110: 3187-3192
        • Kistler P.M.
        • Fynn S.P.
        • Haqqani H.
        • et al.
        Focal atrial tachycardia from the ostium of the coronary sinus: electrocardiographic and electrophysiological characterization and radiofrequency ablation.
        J Am Coll Cardiol. 2005; 45: 1488-1493
        • Ouyang F.
        • Ma J.
        • Ho S.Y.
        • et al.
        Focal atrial tachycardia originating from the non-coronary aortic sinus: electrophysiological characteristics and catheter ablation.
        J Am Coll Cardiol. 2006; 48: 122-131
        • Roberts-Thomson K.C.
        • Kistler P.M.
        • Haqqani H.M.
        • et al.
        Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation.
        J Cardiovasc Electrophysiol. 2007; 18: 367-372
        • Biviano A.B.
        • Bain W.
        • Whang W.
        • et al.
        Focal left atrial tachycardias not associated with prior catheter ablation for atrial fibrillation: clinical and electrophysiological characteristics.
        Pacing Clin Electrophysiol. 2012; 35: 17-27
        • Walters T.E.
        • Kistler P.M.
        • Kalman J.M.
        Radiofrequency ablation for atrial tachycardia and atrial flutter.
        Heart Lung Circ. 2012; 21: 386-394
        • Lee G.
        • Sanders P.
        • Kalman J.M.
        Catheter ablation of atrial arrhythmias: state of the art.
        Lancet. 2012; 380: 1509-1519
        • Gillette P.C.
        • Garson Jr, A.
        Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia.
        Circulation. 1977; 56: 571-575
        • Mehta A.V.
        • Sanchez G.R.
        • Sacks E.J.
        • et al.
        Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.
        J Am Coll Cardiol. 1988; 11: 379-385
        • Markowitz S.M.
        • Stein K.M.
        • Mittal S.
        • et al.
        Differential effects of adenosine on focal and macroreentrant atrial tachycardia.
        J Cardiovasc Electrophysiol. 1999; 10: 489-502
        • Reisinger J.
        • Gstrein C.
        • Winter T.
        • et al.
        Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks.
        Am J Emerg Med. 2010; 28: 159-165
        • Engelstein E.D.
        • Lippman N.
        • Stein K.M.
        • et al.
        Mechanism-specific effects of adenosine on atrial tachycardia.
        Circulation. 1994; 89: 2645-2654
        • Eidher U.
        • Freihoff F.
        • Kaltenbrunner W.
        • et al.
        Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia.
        Pacing Clin Electrophysiol. 2006; 29: 358-362
        • de Loma-Osorio F.
        • Diaz-Infante E.
        • et al.
        Spanish Catheter Ablation Registry. 12th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2012).
        Rev Esp Cardiol (Engl Ed). 2013; 66: 983-992
        • Liu X.
        • Dong J.
        • Ho S.Y.
        • et al.
        Atrial tachycardia arising adjacent to noncoronary aortic sinus: distinctive atrial activation patterns and anatomic insights.
        J Am Coll Cardiol. 2010; 56: 796-804
        • Creamer J.E.
        • Nathan A.W.
        • Camm A.J.
        Successful treatment of atrial tachycardias with flecainide acetate.
        Br Heart J. 1985; 53: 164-166
        • Kunze K.P.
        • Kuck K.H.
        • Schlüter M.
        • et al.
        Effect of encainide and flecainide on chronic ectopic atrial tachycardia.
        J Am Coll Cardiol. 1986; 7: 1121-1126
        • von Bernuth G.
        • Engelhardt W.
        • Kramer H.H.
        • et al.
        Atrial automatic tachycardia in infancy and childhood.
        Eur Heart J. 1992; 13: 1410-1415
        • Lucet V.
        • Do Ngoc D.
        • Fidelle J.
        • et al.
        [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
        Arch Mal Coeur Vaiss. 1987; 80: 1385-1393
        • Heusch A.
        • Kramer H.H.
        • Krogmann O.N.
        • et al.
        Clinical experience with propafenone for cardiac arrhythmias in the young.
        Eur Heart J. 1994; 15: 1050-1056
        • Colloridi V.
        • Perri C.
        • Ventriglia F.
        • et al.
        Oral sotalol in pediatric atrial ectopic tachycardia.
        Am Heart J. 1992; 123: 254-256
        • Guccione P.
        • Paul T.
        • Garson Jr, A.
        Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.
        J Am Coll Cardiol. 1990; 15: 1118-1124
        • Coumel P.
        • Fidelle J.
        Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.
        Am Heart J. 1980; 100: 1063-1069
        • Miyazaki A.
        • Ohuchi H.
        • Kurosaki K.
        • et al.
        Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.
        Circ J. 2008; 72: 1998-2003
        • Kang K.T.
        • Etheridge S.P.
        • Kantoch M.J.
        • et al.
        Current management of focal atrial tachycardia in children: a multicenter experience.
        Circ Arrhythm Electrophysiol. 2014; 7: 664-670
        • Wang K.
        • Goldfarb B.L.
        • Gobel F.L.
        • et al.
        Multifocal atrial tachycardia.
        Arch Intern Med. 1977; 137: 161-164
        • Bittar G.
        • Friedman H.S.
        The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants.
        Chest. 1991; 99: 1415-1420
        • Iseri L.T.
        • Fairshter R.D.
        • Hardemann J.L.
        • et al.
        Magnesium and potassium therapy in multifocal atrial tachycardia.
        Am Heart J. 1985; 110: 789-794
        • Kastor J.A.
        Multifocal atrial tachycardia.
        N Engl J Med. 1990; 322: 1713-1717
        • Arsura E.L.
        • Solar M.
        • Lefkin A.S.
        • et al.
        Metoprolol in the treatment of multifocal atrial tachycardia.
        Crit Care Med. 1987; 15: 591-594
        • Levine J.H.
        • Michael J.R.
        • Guarnieri T.
        Treatment of multifocal atrial tachycardia with verapamil.
        N Engl J Med. 1985; 312: 21-25
        • Salerno D.M.
        • Anderson B.
        • Sharkey P.J.
        • et al.
        Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment.
        Ann Intern Med. 1987; 107: 623-628
        • Hazard P.B.
        • Burnett C.R.
        Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes.
        Chest. 1987; 91: 68-70
        • Hazard P.B.
        • Burnett C.R.
        Treatment of multifocal atrial tachycardia with metoprolol.
        Crit Care Med. 1987; 15: 20-25
        • Mehta D.
        • Wafa S.
        • Ward D.E.
        • et al.
        Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia.
        Lancet. 1988; 1: 1181-1185
        • Wen Z.C.
        • Chen S.A.
        • Tai C.T.
        • et al.
        Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia.
        Circulation. 1998; 98: 2716-2723
        • Glatter K.A.
        • Cheng J.
        • Dorostkar P.
        • et al.
        Electrophysiologic effects of adenosine in patients with supraventricular tachycardia.
        Circulation. 1999; 99: 1034-1040
        • Dougherty A.H.
        • Jackman W.M.
        • Naccarelli G.V.
        • et al.
        Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group.
        Am J Cardiol. 1992; 70: 587-592
        • Waxman H.L.
        • Myerburg R.J.
        • Appel R.
        • et al.
        Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.
        Ann Intern Med. 1981; 94: 1-6
        • Amsterdam E.A.
        • Kulcyski J.
        • Ridgeway M.G.
        Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias.
        J Clin Pharmacol. 1991; 31: 714-718
        • Das G.
        • Tschida V.
        • Gray R.
        • et al.
        Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents.
        J Clin Pharmacol. 1988; 28: 746-750
        • Alboni P.
        • Tomasi C.
        • Menozzi C.
        • et al.
        Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
        J Am Coll Cardiol. 2001; 37: 548-553
        • Yeh S.J.
        • Lin F.C.
        • Chou Y.Y.
        • et al.
        Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol.
        Circulation. 1985; 71: 104-109
        • Rinkenberger R.L.
        • Prystowsky E.N.
        • Heger J.J.
        • et al.
        Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.
        Circulation. 1980; 62: 996-1010
        • D’Este D.
        • Zoppo F.
        • Bertaglia E.
        • et al.
        Long-term outcome of patients with atrioventricular node reentrant tachycardia.
        Int J Cardiol. 2007; 115: 350-353
        • Langberg J.J.
        • Leon A.
        • Borganelli M.
        • et al.
        A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia.
        Circulation. 1993; 87: 1551-1556
        • Kalbfleisch S.J.
        • Strickberger S.A.
        • Williamson B.
        • et al.
        Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia.
        J Am Coll Cardiol. 1994; 23: 716-723
        • Kay G.N.
        • Epstein A.E.
        • Dailey S.M.
        • et al.
        Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit.
        Circulation. 1992; 85: 1675-1688
        • Bogun F.
        • Knight B.
        • Weiss R.
        • et al.
        Slow pathway ablation in patients with documented but noninducible paroxysmal supraventricular tachycardia.
        J Am Coll Cardiol. 1996; 28: 1000-1004
        • O’Hara G.E.
        • Philippon F.
        • Champagne J.
        • et al.
        Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital.
        Can J Cardiol. 2007; 23: 67B-70B
        • Gambhir D.S.
        • Bhargava M.
        • Arora R.
        • et al.
        Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
        Indian Heart J. 1995; 47: 237-243
        • Musto B.
        • Cavallaro C.
        • Musto A.
        • et al.
        Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
        Am Heart J. 1992; 124: 110-115
        • Munger T.M.
        • Packer D.L.
        • Hammill S.C.
        • et al.
        A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989.
        Circulation. 1993; 87: 866-873
        • Pappone C.
        • Vicedomini G.
        • Manguso F.
        • et al.
        Wolff-Parkinson-white syndrome in the era of catheter ablation: insights from a registry study of 2169 patients.
        Circulation. 2014; 130: 811-819
        • Timmermans C.
        • Smeets J.L.
        • Rodriguez L.M.
        • et al.
        Aborted sudden death in the Wolff-Parkinson-White syndrome.
        Am J Cardiol. 1995; 76: 492-494
        • Klein G.J.
        • Bashore T.M.
        • Sellers T.D.
        • et al.
        Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
        N Engl J Med. 1979; 301: 1080-1085
        • Bromberg B.I.
        • Lindsay B.D.
        • Cain M.E.
        • et al.
        Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1996; 27: 690-695
        • Santinelli V.
        • Radinovic A.
        • Manguso F.
        • et al.
        The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children.
        J Am Coll Cardiol. 2009; 53: 275-280
        • Neumar R.W.
        • Otto C.W.
        • Link M.S.
        • et al.
        Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
        Circulation. 2010; 122: S729-S767
        • Smith G.D.
        • Dyson K.
        • Taylor D.
        • et al.
        Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia.
        Cochrane Database Syst Rev. 2013; 3: CD009502
        • Delaney B.
        • Loy J.
        • Kelly A.-M.
        The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis.
        Eur J Emerg Med. 2011; 18: 148-152
        • Furlong R.
        • Gerhardt R.T.
        • Farber P.
        • et al.
        Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control.
        Am J Emerg Med. 1995; 13: 383-388
        • Schatz I.
        • Ordog G.J.
        • Karody R.
        • et al.
        Wolff-Parkinson-White syndrome presenting in atrial fibrillation.
        Ann Emerg Med. 1987; 16: 574-578
        • Mittal S.
        • Ayati S.
        • Stein K.M.
        • et al.
        Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks.
        Circulation. 2000; 101: 1282-1287
        • Glatter K.A.
        • Dorostkar P.C.
        • Yang Y.
        • et al.
        Electrophysiological effects of ibutilide in patients with accessory pathways.
        Circulation. 2001; 104: 1933-1939
        • Sellers Jr., T.D.
        • Campbell R.W.
        • Bashore T.M.
        • et al.
        Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
        Circulation. 1977; 55: 15-22
        • Huycke E.C.
        • Sung R.J.
        • Dias V.C.
        • et al.
        Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study.
        J Am Coll Cardiol. 1989; 13: 538-544
        • Hamer A.
        • Peter T.
        • Platt M.
        • et al.
        Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
        Am Heart J. 1981; 101: 600-612
        • Hombach V.
        • Braun V.
        • Hopp H.W.
        • et al.
        Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise.
        Klin Wochenschr. 1981; 59: 123-133
        • Morady F.
        • DiCarlo Jr., L.A.
        • Baerman J.M.
        • et al.
        Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
        Pacing Clin Electrophysiol. 1987; 10: 492-496
        • Sellers Jr., T.D.
        • Bashore T.M.
        • Gallagher J.J.
        Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.
        Circulation. 1977; 56: 260-267
        • Sheinman B.D.
        • Evans T.
        Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
        Br Med J (Clin Res Ed). 1982; 285: 999-1000
        • Boriani G.
        • Biffi M.
        • Frabetti L.
        • et al.
        Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
        Am Heart J. 1996; 131: 1214-1216
        • Shiraishi H.
        • Ishibashi K.
        • Urao N.
        • et al.
        Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia.
        Intern Med. 2002; 41: 445-448
        • Schützenberger W.
        • Leisch F.
        • Gmeiner R.
        Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report.
        Int J Cardiol. 1987; 16: 93-95
        • Jackman W.M.
        • Wang X.Z.
        • Friday K.J.
        • et al.
        Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current.
        N Engl J Med. 1991; 324: 1605-1611
        • Calkins H.
        • Langberg J.
        • Sousa J.
        • et al.
        Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome.
        Circulation. 1992; 85: 1337-1346
        • Dagres N.
        • Clague J.R.
        • Kottkamp H.
        • et al.
        Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up.
        Eur Heart J. 1999; 20: 1826-1832
        • Schläpfer J.
        • Fromer M.
        Late clinical outcome after successful radiofrequency catheter ablation of accessory pathways.
        Eur Heart J. 2001; 22: 605-609
        • Belhassen B.
        • Rogowski O.
        • Glick A.
        • et al.
        Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients.
        Isr Med Assoc J. 2007; 9: 265-270
        • Kugler J.D.
        • Danford D.A.
        • Deal B.J.
        • et al.
        Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society.
        N Engl J Med. 1994; 330: 1481-1487
        • Kugler J.D.
        • Danford D.A.
        • Houston K.
        • et al.
        Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry.
        Am J Cardiol. 1997; 80: 1438-1443
        • Sakurai M.
        • Yasuda H.
        • Kato N.
        • et al.
        Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
        Am Heart J. 1983; 105: 619-628
        • Hopson J.R.
        • Buxton A.E.
        • Rinkenberger R.L.
        • et al.
        Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
        Am J Cardiol. 1996; 77: 72A-82A
        • Feld G.K.
        • Nademanee K.
        • Weiss J.
        • et al.
        Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
        J Am Coll Cardiol. 1984; 3: 1298-1307
        • Feld G.K.
        • Nademanee K.
        • Stevenson W.
        • et al.
        Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
        Am Heart J. 1988; 115: 102-107
        • Bauernfeind R.A.
        • Wyndham C.R.
        • Dhingra R.C.
        • et al.
        Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia.
        Circulation. 1980; 62: 1341-1349
        • Sharma A.D.
        • Yee R.
        • Guiraudon G.
        • et al.
        Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1987; 10: 373-381
        • Gaita F.
        • Giustetto C.
        • Riccardi R.
        • et al.
        Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death.
        Am J Cardiol. 1989; 64: 487-490
        • Spar D.S.
        • Silver E.S.
        • Hordof A.J.
        • et al.
        Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location.
        Am J Cardiol. 2012; 109: 1011-1014
        • Wackel P.
        • Irving C.
        • Webber S.
        • et al.
        Risk stratification in Wolff-Parkinson-White syndrome: the correlation between noninvasive and invasive testing in pediatric patients.
        Pacing Clin Electrophysiol. 2012; 35: 1451-1457
        • Beckman K.J.
        • Gallastegui J.L.
        • Bauman J.L.
        • et al.
        The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1990; 15: 640-647
        • Pappone C.
        • Vicedomini G.
        • Manguso F.
        • et al.
        Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study.
        Circulation. 2012; 125: 661-668
        • Rinne C.
        • Klein G.J.
        • Sharma A.D.
        • et al.
        Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome.
        Am J Cardiol. 1987; 60: 576-579
        • Brembilla-Perrot B.
        • Holban I.
        • Houriez P.
        • et al.
        Influence of age on the potential risk of sudden death in asymptomatic Wolff-Parkinson-White syndrome.
        Pacing Clin Electrophysiol. 2001; 24: 1514-1518
        • Pappone C.
        • Santinelli V.
        • Manguso F.
        • et al.
        A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome.
        N Engl J Med. 2003; 349: 1803-1811
        • Pappone C.
        • Santinelli V.
        • Rosanio S.
        • et al.
        Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study.
        J Am Coll Cardiol. 2003; 41: 239-244
        • Epstein A.E.
        • Miles W.M.
        • Benditt D.G.
        • et al.
        Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology.
        Circulation. 1996; 94: 1147-1166
        • Klein G.J.
        • Yee R.
        • Sharma A.D.
        Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern.
        N Engl J Med. 1989; 320: 1229-1233
        • Leitch J.W.
        • Klein G.J.
        • Yee R.
        • et al.
        Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern.
        Circulation. 1990; 82: 1718-1723
        • Milstein S.
        • Sharma A.D.
        • Klein G.J.
        Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern.
        Am J Cardiol. 1986; 57: 1097-1100
        • Satoh M.
        • Aizawa Y.
        • Funazaki T.
        • et al.
        Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern.
        Pacing Clin Electrophysiol. 1989; 12: 413-420
        • Havránek S.
        • Simek J.
        • St’ovĺǒek P.
        • et al.
        Distribution of mean cycle length in cavo-tricuspid isthmus dependent atrial flutter.
        Physiol Res. 2012; 61: 43-51
        • Waldo A.L.
        • Feld G.K.
        Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications.
        J Am Coll Cardiol. 2008; 51: 779-786
        • Pérez F.J.
        • Schubert C.M.
        • Parvez B.
        • et al.
        Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis.
        Circ Arrhythm Electrophysiol. 2009; 2: 393-401
        • Ellis K.
        • Wazni O.
        • Marrouche N.
        • et al.
        Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence.
        J Cardiovasc Electrophysiol. 2007; 18: 799-802
        • Hsieh M.-H.
        • Tai C.-T.
        • Chiang C.-E.
        • et al.
        Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients.
        J Interv Card Electrophysiol. 2002; 7: 225-231
        • Tai C.T.
        • Chen S.A.
        • Chiang C.E.
        • et al.
        Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias.
        J Cardiovasc Electrophysiol. 1998; 9: 115-121
        • Paydak H.
        • Kall J.G.
        • Burke M.C.
        • et al.
        Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course.
        Circulation. 1998; 98: 315-322
        • Chinitz J.S.
        • Gerstenfeld E.P.
        • Marchlinski F.E.
        • et al.
        Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up.
        Heart Rhythm. 2007; 4: 1029-1033
        • Teh A.W.
        • Medi C.
        • Lee G.
        • et al.
        Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair.
        Pacing Clin Electrophysiol. 2011; 34: 431-435
        • Gerstenfeld E.P.
        • Callans D.J.
        • Dixit S.
        • et al.
        Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation.
        Circulation. 2004; 110: 1351-1357
        • Chugh A.
        • Oral H.
        • Lemola K.
        • et al.
        Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation.
        Heart Rhythm. 2005; 2: 464-471
        • Veenhuyzen G.D.
        • Knecht S.
        • O’Neill M.D.
        • et al.
        Atrial tachycardias encountered during and after catheter ablation for atrial fibrillation: part I: classification, incidence, management.
        Pacing Clin Electrophysiol. 2009; 32: 393-398
        • Karch M.R.
        • Zrenner B.
        • Deisenhofer I.
        • et al.
        Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies.
        Circulation. 2005; 111: 2875-2880
        • Sawhney N.
        • Anousheh R.
        • Chen W.
        • et al.
        Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation.
        Circ Arrhythm Electrophysiol. 2010; 3: 243-248
        • Neumann T.
        • Vogt J.
        • Schumacher B.
        • et al.
        Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study.
        J Am Coll Cardiol. 2008; 52: 273-278
        • Ellenbogen K.A.
        • Stambler B.S.
        • Wood M.A.
        • et al.
        Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
        J Am Coll Cardiol. 1996; 28: 130-136
        • Suttorp M.J.
        • Kingma J.H.
        • Jessurun E.R.
        • et al.
        The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
        J Am Coll Cardiol. 1990; 16: 1722-1727
        • Stambler B.S.
        • Wood M.A.
        • Ellenbogen K.A.
        • et al.
        Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
        Circulation. 1996; 94: 1613-1621
        • Kingma J.H.
        • Suttorp M.J.
        Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil.
        Am J Cardiol. 1992; 70: 56A-60A
        • Vos M.A.
        • Golitsyn S.R.
        • Stangl K.
        • et al.
        Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
        Heart. 1998; 79: 568-575
        • Volgman A.S.
        • Carberry P.A.
        • Stambler B.
        • et al.
        Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
        J Am Coll Cardiol. 1998; 31: 1414-1419
        • Steinwender C.
        • Hönig S.
        • Kypta A.
        • et al.
        Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
        Int J Cardiol. 2010; 141: 260-265
        • Singh S.
        • Zoble R.G.
        • Yellen L.
        • et al.
        Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
        Circulation. 2000; 102: 2385-2390
        • Blackshear J.L.
        • Stambler B.S.
        • Strauss W.E.
        • et al.
        Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter.
        Am J Cardiol. 1996; 78: 1246-1250
        • Singh B.N.
        • Hecht H.S.
        • Nademanee K.
        • et al.
        Electrophysiologic and hemodynamic effects of slow-channel blocking drugs.
        Prog Cardiovasc Dis. 1982; 25: 103-132
        • Akhtar M.
        • Tchou P.
        • Jazayeri M.
        Use of calcium channel entry blockers in the treatment of cardiac arrhythmias.
        Circulation. 1989; 80: IV31-IV39
        • Delle Karth G.
        • Geppert A.
        • Neunteufl T.
        • et al.
        Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.
        Crit Care Med. 2001; 29: 1149-1153
        • Ellenbogen K.A.
        • Dias V.C.
        • Plumb V.J.
        • et al.
        A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study.
        J Am Coll Cardiol. 1991; 18: 891-897
        • Ellenbogen K.A.
        • Dias V.C.
        • Cardello F.P.
        • et al.
        Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.
        Am J Cardiol. 1995; 75: 45-49
        • Platia E.V.
        • Michelson E.L.
        • Porterfield J.K.
        • et al.
        Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
        Am J Cardiol. 1989; 63: 925-929
        • Salerno D.M.
        • Dias V.C.
        • Kleiger R.E.
        • et al.
        Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group.
        Am J Cardiol. 1989; 63: 1046-1051
        • Gallagher M.M.
        • Guo X.H.
        • Poloniecki J.D.
        • et al.
        Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter.
        J Am Coll Cardiol. 2001; 38: 1498-1504
        • Botkin S.B.
        • Dhanekula L.S.
        • Olshansky B.
        Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs.
        Am Heart J. 2003; 145: 233-238
        • Pizzale S.
        • Lemery R.
        • Green M.S.
        • et al.
        Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter.
        Can J Cardiol. 2009; 25: 469-472
        • Van Gelder I.C.
        • Crijns H.J.
        • Van Gilst W.H.
        • et al.
        Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.
        Am J Cardiol. 1991; 68: 41-46
        • Boriani G.
        • Tukkie R.
        • Manolis A.S.
        • et al.
        Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
        Eur Heart J. 2014; 35: 2352-2362
        • Mitchell A.R.J.
        • Spurrell P.A.R.
        • Cheatle L.
        • et al.
        Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: randomised study comparing subthreshold and nominal pacing outputs.
        Heart. 2002; 87: 433-437
        • Gillis A.M.
        • Unterberg-Buchwald C.
        • Schmidinger H.
        • et al.
        Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
        J Am Coll Cardiol. 2002; 40: 1653-1659
        • Waldo A.L.
        • MacLean W.A.
        • Cooper T.B.
        • et al.
        Use of temporarily placed epicardial atrial wire electrodes for the diagnosis and treatment of cardiac arrhythmias following open-heart surgery.
        J Thorac Cardiovasc Surg. 1978; 76: 500-505
        • Peters R.W.
        • Shorofsky S.R.
        • Pelini M.
        • et al.
        Overdrive atrial pacing for conversion of atrial flutter: comparison of postoperative with nonpostoperative patients.
        Am Heart J. 1999; 137: 100-103
        • Ghali W.A.
        • Wasil B.I.
        • Brant R.
        • et al.
        Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis.
        Am J Med. 2005; 118: 101-107
        • Clemo H.F.
        • Wood M.A.
        • Gilligan D.M.
        • et al.
        Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.
        Am J Cardiol. 1998; 81: 594-598
        • Roberts S.A.
        • Diaz C.
        • Nolan P.E.
        • et al.
        Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter.
        Am J Cardiol. 1993; 72: 567-573
        • Natale A.
        • Newby K.H.
        • Pisanó E.
        • et al.
        Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter.
        J Am Coll Cardiol. 2000; 35: 1898-1904
        • Bastani H.
        • Drca N.
        • Insulander P.
        • et al.
        Cryothermal vs. radiofrequency ablation as atrial flutter therapy: a randomized comparison.
        Europace. 2013; 15: 420-428
        • Poty H.
        • Saoudi N.
        • Nair M.
        • et al.
        Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of isthmus block: application to ablation during sinus rhythm.
        Circulation. 1996; 94: 3204-3213
        • Schwartzman D.
        • Callans D.J.
        • Gottlieb C.D.
        • et al.
        Conduction block in the inferior vena caval-tricuspid valve isthmus: association with outcome of radiofrequency ablation of type I atrial flutter.
        J Am Coll Cardiol. 1996; 28: 1519-1531
        • Delacretaz E.
        • Ganz L.I.
        • Soejima K.
        • et al.
        Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping.
        J Am Coll Cardiol. 2001; 37: 1665-1676
        • Jaïs P.
        • Shah D.C.
        • Haïssaguerre M.
        • et al.
        Mapping and ablation of left atrial flutters.
        Circulation. 2000; 101: 2928-2934
        • Da Costa A.
        • Thevenin J.
        • Roche F.
        • et al.
        Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter.
        Circulation. 2006; 114: 1676-1681
        • Pedersen O.D.
        • Bagger H.
        • Keller N.
        • et al.
        Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
        Circulation. 2001; 104: 292-296
        • Benditt D.G.
        • Williams J.H.
        • Jin J.
        • et al.
        Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
        Am J Cardiol. 1999; 84: 270-277
        • Reithmann C.
        • Hoffmann E.
        • Spitzlberger G.
        • et al.
        Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation.
        Eur Heart J. 2000; 21: 565-572
        • Huang D.T.
        • Monahan K.M.
        • Zimetbaum P.
        • et al.
        Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
        J Cardiovasc Electrophysiol. 1998; 9: 462-469
        • Schumacher B.
        • Jung W.
        • Lewalter T.
        • et al.
        Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
        Am J Cardiol. 1999; 83: 710-713
        • Mohanty S.
        • Mohanty P.
        • Di Biase L.
        • et al.
        Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL).
        Circulation. 2013; 127: 1853-1860
        • Wazni O.
        • Marrouche N.F.
        • Martin D.O.
        • et al.
        Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
        Circulation. 2003; 108: 2479-2483
        • Coffey J.O.
        • d’Avila A.
        • Dukkipati S.
        • et al.
        Catheter ablation of scar-related atypical atrial flutter.
        Europace. 2013; 15: 414-419
        • Aliot E.
        • Denjoy I.
        Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
        Am J Cardiol. 1996; 77: 66A-71A
        • Van Gelder I.C.
        • Crijns H.J.
        • Van Gilst W.H.
        • et al.
        Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
        Am J Cardiol. 1989; 64: 1317-1321
        • Pietersen A.H.
        • Hellemann H.
        Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group.
        Am J Cardiol. 1991; 67: 713-717
        • Ruder M.A.
        • Davis J.C.
        • Eldar M.
        • et al.
        Clinical and electrophysiologic characterization of automatic junctional tachycardia in adults.
        Circulation. 1986; 73: 930-937
        • Wyndham C.R.
        • Dhingra R.C.
        • Smith T.
        • et al.
        Concealed nonparoxysmal junctional tachycardia.
        Circulation. 1979; 60: 707-710
        • Konecke L.L.
        • Knoebel S.B.
        Nonparoxysmal junctional tachycardia complicating acute myocardial infarction.
        Circulation. 1972; 45: 367-374
        • Fishenfeld J.
        • Desser K.B.
        • Benchimol A.
        Non-paroxysmal A-V junctional tachycardia associated with acute myocardial infarction.
        Am Heart J. 1973; 86: 754-758
        • Kumagai K.
        • Yamato H.
        • Yamanouchi Y.
        • et al.
        Automatic junctional tachycardia in an adult.
        Clin Cardiol. 1990; 13: 813-816
        • Cook J.R.
        • Steinberg J.S.
        An incessant form of junctional ectopic tachycardia in an adult responsive to a class 1C agent.
        Am Heart J. 1991; 122: 1487-1489
        • Kuck K.H.
        • Kunze K.P.
        • Schlüter M.
        • et al.
        Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
        Am J Cardiol. 1988; 62: 37L-44L
        • Mamchur S.E.
        • Kurilin M.Y.
        High-amplitude pace mapping increases safety of radiofrequency catheter ablation of parahisian ectopic foci.
        Pacing Clin Electrophysiol. 2012; 35: 1458-1463
        • Padanilam B.J.
        • Manfredi J.A.
        • Steinberg L.A.
        • et al.
        Differentiating junctional tachycardia and atrioventricular node re-entry tachycardia based on response to atrial extrastimulus pacing.
        J Am Coll Cardiol. 2008; 52: 1711-1717
        • Scheinman M.M.
        • Gonzalez R.P.
        • Cooper M.W.
        • et al.
        Clinical and electrophysiologic features and role of catheter ablation techniques in adult patients with automatic atrioventricular junctional tachycardia.
        Am J Cardiol. 1994; 74: 565-572
        • Fan R.
        • Tardos J.G.
        • Almasry I.
        • et al.
        Novel use of atrial overdrive pacing to rapidly differentiate junctional tachycardia from atrioventricular nodal reentrant tachycardia.
        Heart Rhythm. 2011; 8: 840-844
        • Srivathsan K.
        • Gami A.S.
        • Barrett R.
        • et al.
        Differentiating atrioventricular nodal reentrant tachycardia from junctional tachycardia: novel application of the delta H-A interval.
        J Cardiovasc Electrophysiol. 2008; 19: 1-6
        • Hamdan M.
        • Van Hare G.F.
        • Fisher W.
        • et al.
        Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia.
        Am J Cardiol. 1996; 78: 1292-1297
        • Law I.H.
        • Von Bergen N.H.
        • Gingerich J.C.
        • et al.
        Transcatheter cryothermal ablation of junctional ectopic tachycardia in the normal heart.
        Heart Rhythm. 2006; 3: 903-907
        • Garson Jr., A.
        • Gillette P.C.
        Electrophysiologic studies of supraventricular tachycardia in children. I. Clinical-electrophysiologic correlations.
        Am Heart J. 1981; 102: 233-250
        • Ko J.K.
        • Deal B.J.
        • Strasburger J.F.
        • et al.
        Supraventricular tachycardia mechanisms and their age distribution in pediatric patients.
        Am J Cardiol. 1992; 69: 1028-1032
        • Weindling S.N.
        • Saul J.P.
        • Walsh E.P.
        Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants.
        Am Heart J. 1996; 131: 66-72
        • Garson Jr., A.
        • Gillette P.C.
        • McNamara D.G.
        Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients.
        J Pediatr. 1981; 98: 875-882
        • Dixon J.
        • Foster K.
        • Wyllie J.
        • et al.
        Guidelines and adenosine dosing in supraventricular tachycardia.
        Arch Dis Child. 2005; 90: 1190-1191
        • Dĺaz-Parra S.
        • Sánchez-Yañ̆ez P.
        • Zabala-Argüelles I.
        • et al.
        Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department.
        Pediatr Emerg Care. 2014; 30: 388-393
        • Losek J.D.
        • Endom E.
        • Dietrich A.
        • et al.
        Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review.
        Ann Emerg Med. 1999; 33: 185-191
        • Deal B.J.
        • Keane J.F.
        • Gillette P.C.
        • et al.
        Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up.
        J Am Coll Cardiol. 1985; 5: 130-135
        • Villain E.
        • Bonnet D.
        • Acar P.
        • et al.
        [Recommendations for the treatment of recurrent supraventricular tachycardia in infants].
        Arch Pediatr. 1998; 5: 133-138
        • Fish F.A.
        • Gillette P.C.
        • Benson Jr, D.W.
        Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
        J Am Coll Cardiol. 1991; 18: 356-365
        • Lee P.-C.
        • Hwang B.
        • Chen S.-A.
        • et al.
        The results of radiofrequency catheter ablation of supraventricular tachycardia in children.
        Pacing Clin Electrophysiol. 2007; 30: 655-661
        • Van Hare G.F.
        • Javitz H.
        • Carmelli D.
        • et al.
        Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes.
        J Cardiovasc Electrophysiol. 2004; 15: 759-770
        • Aiyagari R.
        • Saarel E.V.
        • Etheridge S.P.
        • et al.
        Radiofrequency ablation for supraventricular tachycardia in children < or =15 kg is safe and effective.
        Pediatr Cardiol. 2005; 26: 622-626
        • Blaufox A.D.
        • Felix G.L.
        • Saul J.P.
        Radiofrequency catheter ablation in infants </=18 months old: when is it done and how do they fare?: short-term data from the pediatric ablation registry.
        Circulation. 2001; 104: 2803-2808
        • Blaufox A.D.
        • Paul T.
        • Saul J.P.
        Radiofrequency catheter ablation in small children: relationship of complications to application dose.
        Pacing Clin Electrophysiol. 2004; 27: 224-229
        • Kantoch M.J.
        • Gulamhusein S.S.
        • Sanatani S.
        Short- and long-term outcomes in children undergoing radiofrequency catheter ablation before their second birthday.
        Can J Cardiol. 2011; 27: 523.e3-523.e9
        • Schaffer M.S.
        • Gow R.M.
        • Moak J.P.
        • et al.
        Mortality following radiofrequency catheter ablation (from the Pediatric Radiofrequency Ablation Registry). Participating members of the Pediatric Electrophysiology Society.
        Am J Cardiol. 2000; 86: 639-643
        • Collins K.K.
        • Van Hare G.F.
        • Kertesz N.J.
        • et al.
        Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies.
        J Am Coll Cardiol. 2009; 53: 690-697
        • Batra A.S.
        • Chun D.S.
        • Johnson T.R.
        • et al.
        A prospective analysis of the incidence and risk factors associated with junctional ectopic tachycardia following surgery for congenital heart disease.
        Pediatr Cardiol. 2006; 27: 51-55
        • Andreasen J.B.
        • Johnsen S.P.
        • Ravn H.B.
        Junctional ectopic tachycardia after surgery for congenital heart disease in children.
        Intensive Care Med. 2008; 34: 895-902
        • Haas N.A.
        • Camphausen C.K.
        Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia.
        J Thorac Cardiovasc Surg. 2008; 136: 1215-1222
        • Laird W.P.
        • Snyder C.S.
        • Kertesz N.J.
        • et al.
        Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children.
        Pediatr Cardiol. 2003; 24: 133-137
        • Kovacikova L.
        • Hakacova N.
        • Dobos D.
        • et al.
        Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia.
        Ann Thorac Surg. 2009; 88: 616-622
        • Walsh E.P.
        • Saul J.P.
        • Sholler G.F.
        • et al.
        Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease.
        J Am Coll Cardiol. 1997; 29: 1046-1053
        • Sanatani S.
        • Potts J.E.
        • Reed J.H.
        • et al.
        The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants.
        Circ Arrhythm Electrophysiol. 2012; 5: 984-991
        • van Engelen A.D.
        • Weijtens O.
        • Brenner J.I.
        • et al.
        Management outcome and follow-up of fetal tachycardia.
        J Am Coll Cardiol. 1994; 24: 1371-1375
        • Bouchardy J.
        • Therrien J.
        • Pilote L.
        • et al.
        Atrial arrhythmias in adults with congenital heart disease.
        Circulation. 2009; 120: 1679-1686
        • Bernier M.
        • Marelli A.J.
        • Pilote L.
        • et al.
        Atrial arrhythmias in adult patients with right- versus left-sided congenital heart disease anomalies.
        Am J Cardiol. 2010; 106: 547-551
        • Engelfriet P.
        • Boersma E.
        • Oechslin E.
        • et al.
        The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease.
        Eur Heart J. 2005; 26: 2325-2333
        • Trojnarska O.
        • Grajek S.
        • Kramer L.
        • et al.
        Risk factors of supraventricular arrhythmia in adults with congenital heart disease.
        Cardiol J. 2009; 16: 218-226
        • Verheugt C.L.
        • Uiterwaal C.S.P.M.
        • van der Velde E.T.
        • et al.
        Gender and outcome in adult congenital heart disease.
        Circulation. 2008; 118: 26-32
        • Akar J.G.
        • Kok L.C.
        • Haines D.E.
        • et al.
        Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease.
        J Am Coll Cardiol. 2001; 38: 377-384
        • Collins K.K.
        • Love B.A.
        • Walsh E.P.
        • et al.
        Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease.
        Am J Cardiol. 2000; 86: 969-974
        • de Groot N.M.S.
        • Zeppenfeld K.
        • Wijffels M.C.
        • et al.
        Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction.
        Heart Rhythm. 2006; 3: 526-535
        • Koyak Z.
        • Kroon B.
        • de Groot J.R.
        • et al.
        Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias.
        Am J Cardiol. 2013; 112: 1461-1467
        • Mah D.Y.
        • Alexander M.E.
        • Cecchin F.
        • et al.
        The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle.
        J Cardiovasc Electrophysiol. 2011; 22: 1013-1017
        • Wasmer K.
        • Köbe J.
        • Dechering D.G.
        • et al.
        Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair.
        Int J Cardiol. 2013; 168: 2447-2452
        • de Groot N.M.S.
        • Atary J.Z.
        • Blom N.A.
        • et al.
        Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences.
        Circ Arrhythm Electrophysiol. 2010; 3: 148-154
        • Hårdhammar P.A.
        • van Beusekom H.M.
        • Emanuelsson H.U.
        • et al.
        Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries.
        Circulation. 1996; 93: 423-430
        • Tanner H.
        • Lukac P.
        • Schwick N.
        • et al.
        Irrigated-tip catheter ablation of intraatrial reentrant tachycardia in patients late after surgery of congenital heart disease.
        Heart Rhythm. 2004; 1: 268-275
        • Triedman J.K.
        • Saul J.P.
        • Weindling S.N.
        • et al.
        Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease.
        Circulation. 1995; 91: 707-714
        • DeMazumder D.
        • Lake D.E.
        • Cheng A.
        • et al.
        Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias.
        Circ Arrhythm Electrophysiol. 2013; 6: 555-561
        • Yap S.-C.
        • Harris L.
        • Silversides C.K.
        • et al.
        Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery.
        J Am Coll Cardiol. 2010; 56: 1589-1596
        • Ammash N.M.
        • Phillips S.D.
        • Hodge D.O.
        • et al.
        Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease.
        Int J Cardiol. 2012; 154: 270-274
        • Pass R.H.
        • Liberman L.
        • Al-Fayaddh M.
        • et al.
        Continuous intravenous diltiazem infusion for short-term ventricular rate control in children.
        Am J Cardiol. 2000; 86 (A9): 559-562
        • Garnock-Jones K.P.
        Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension.
        Drugs. 2012; 72: 109-132
        • diMarco J.P.
        • Sellers T.D.
        • Lerman B.B.
        • et al.
        Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.
        J Am Coll Cardiol. 1985; 6: 417-425
        • Haines D.E.
        • DiMarco J.P.
        Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.
        J Am Coll Cardiol. 1990; 15: 1345-1354
        • Kall J.G.
        • Kopp D.
        • Olshansky B.
        • et al.
        Adenosine-sensitive atrial tachycardia.
        Pacing Clin Electrophysiol. 1995; 18: 300-306
        • Olshansky B.
        • Okumura K.
        • Hess P.G.
        • et al.
        Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm.
        J Am Coll Cardiol. 1988; 11: 359-364
        • Heisel A.
        • Jung J.
        • Stopp M.
        • et al.
        Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing.
        Eur Heart J. 1997; 18: 866-869
        • Hoyer A.W.
        • Balaji S.
        The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
        Pacing Clin Electrophysiol. 2007; 30: 1003-1008
        • Crawford W.
        • Plumb V.J.
        • Epstein A.E.
        • et al.
        Prospective evaluation of transesophageal pacing for the interruption of atrial flutter.
        Am J Med. 1989; 86: 663-667
        • Rhodes L.A.
        • Walsh E.P.
        • Saul J.P.
        Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure.
        Am Heart J. 1995; 130: 323-327
        • Brockmeier K.
        • Ulmer H.E.
        • Hessling G.
        Termination of atrial reentrant tachycardias by using transesophageal atrial pacing.
        J Electrocardiol. 2002; 35: 159-163
        • Stephenson E.A.
        • Casavant D.
        • Tuzi J.
        • et al.
        Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease.
        Am J Cardiol. 2003; 92: 871-876
        • Rao S.O.
        • Boramanand N.K.
        • Burton D.A.
        • et al.
        Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol.
        Int J Cardiol. 2009; 136: 253-257
        • Wells R.
        • Khairy P.
        • Harris L.
        • et al.
        Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study.
        Pacing Clin Electrophysiol. 2009; 32: 1313-1318
        • Warnes C.A.
        • Williams R.G.
        • Bashore T.M.
        • et al.
        ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2008; 52: e143-e263
        • Khairy P.
        • Van Hare G.F.
        • Balaji S.
        • et al.
        PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).
        Heart Rhythm. 2014; 11: e102-e165
        • Huang C.J.
        • Chiu I.S.
        • Lin F.Y.
        • et al.
        Role of electrophysiological studies and arrhythmia intervention in repairing Ebstein’s anomaly.
        Thorac Cardiovasc Surg. 2000; 48: 347-350
        • Reich J.D.
        • Auld D.
        • Hulse E.
        • et al.
        The Pediatric Radiofrequency Ablation Registry’s experience with Ebstein’s anomaly. Pediatric Electrophysiology Society.
        J Cardiovasc Electrophysiol. 1998; 9: 1370-1377
        • Cappato R.
        • Schlüter M.
        • Weiss C.
        • et al.
        Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein’s anomaly.
        Circulation. 1996; 94: 376-383
        • Misaki T.
        • Watanabe G.
        • Iwa T.
        • et al.
        Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated Ebstein’s anomaly.
        J Thorac Cardiovasc Surg. 1995; 110: 1702-1707
        • Khositseth A.
        • Danielson G.K.
        • Dearani J.A.
        • et al.
        Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome.
        J Thorac Cardiovasc Surg. 2004; 128: 826-833
        • Bockeria L.
        • Golukhova E.
        • Dadasheva M.
        • et al.
        Advantages and disadvantages of one-stage and two-stage surgery for arrhythmias and Ebstein’s anomaly.
        Eur J Cardiothorac Surg. 2005; 28: 536-540
        • Pressley J.C.
        • Wharton J.M.
        • Tang A.S.
        • et al.
        Effect of Ebstein’s anomaly on short- and long-term outcome of surgically treated patients with Wolff-Parkinson-White syndrome.
        Circulation. 1992; 86: 1147-1155
        • Khairy P.
        • Harris L.
        • Landzberg M.J.
        • et al.
        Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study.
        Circ Arrhythm Electrophysiol. 2008; 1: 250-257
        • Lukac P.
        • Pedersen A.K.
        • Mortensen P.T.
        • et al.
        Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?.
        Heart Rhythm. 2005; 2: 64-72
        • Yap S.-C.
        • Harris L.
        • Downar E.
        • et al.
        Evolving electroanatomic substrate and intra-atrial reentrant tachycardia late after Fontan surgery.
        J Cardiovasc Electrophysiol. 2012; 23: 339-345
        • Wu J.
        • Deisenhofer I.
        • Ammar S.
        • et al.
        Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries.
        Europace. 2013; 15: 886-891
        • Jones D.G.
        • Jarman J.W.E.
        • Lyne J.C.
        • et al.
        The safety and efficacy of trans-baffle puncture to enable catheter ablation of atrial tachycardias following the Mustard procedure: a single centre experience and literature review.
        Int J Cardiol. 2013; 168: 1115-1120
        • Scaglione M.
        • Caponi D.
        • Ebrille E.
        • et al.
        Very long-term results of electroanatomic-guided radiofrequency ablation of atrial arrhythmias in patients with surgically corrected atrial septal defect.
        Europace. 2014; : 1800-1807
        • Giamberti A.
        • Chessa M.
        • Abella R.
        • et al.
        Surgical treatment of arrhythmias in adults with congenital heart defects.
        Int J Cardiol. 2008; 129: 37-41
        • Stulak J.M.
        • Dearani J.A.
        • Puga F.J.
        • et al.
        Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease.
        Ann Thorac Surg. 2006; 81: 1780-1784
        • Mavroudis C.
        • Deal B.J.
        • Backer C.L.
        • et al.
        Arrhythmia surgery in patients with and without congenital heart disease.
        Ann Thorac Surg. 2008; 86: 857-868
        • Karamlou T.
        • Silber I.
        • Lao R.
        • et al.
        Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery.
        Ann Thorac Surg. 2006; 81: 1786-1793
        • Deal B.J.
        • Mavroudis C.
        • Backer C.L.
        • et al.
        Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients.
        Circulation. 2002; 106: 575-579
        • Mavroudis C.
        • Backer C.L.
        • Deal B.J.
        • et al.
        Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation.
        J Thorac Cardiovasc Surg. 2001; 122: 863-871
        • Mavroudis C.
        • Deal B.J.
        • Backer C.L.
        • et al.
        J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes.
        Ann Thorac Surg. 2007; 84: 1457-1465